Technology News and Research

RSS
New cell-free antibody generation platform successfully creates neutralizing antibodies effective against SARS-CoV-2

New cell-free antibody generation platform successfully creates neutralizing antibodies effective against SARS-CoV-2

Ultrasonic Flow Meter Ideal for Ultra-Pure Water Applications

Ultrasonic Flow Meter Ideal for Ultra-Pure Water Applications

Differences in DNA methylation could accurately predict progression of liver disease

Differences in DNA methylation could accurately predict progression of liver disease

Researchers develop new method to track the development of cancer cells

Researchers develop new method to track the development of cancer cells

Internet usage boosts cognitive function of retirees, finds study

Internet usage boosts cognitive function of retirees, finds study

EIT Health highlights the urgent need for harnessing data and AI to fight against Alzheimer’s disease

EIT Health highlights the urgent need for harnessing data and AI to fight against Alzheimer’s disease

New surgical mask with an intelligent fabric can instantaneously deactivate SARS-COV-2 virus

New surgical mask with an intelligent fabric can instantaneously deactivate SARS-COV-2 virus

Specially designed lipid nanoparticles overcome resistance to anti-tumor immunotherapy

Specially designed lipid nanoparticles overcome resistance to anti-tumor immunotherapy

Cross-species locomotion features shared by dopamine-deficient worms, mice, and humans

Cross-species locomotion features shared by dopamine-deficient worms, mice, and humans

AI can help with the diagnosis of B-cell lymphomas and related leukemias

AI can help with the diagnosis of B-cell lymphomas and related leukemias

A 100% French nasal vaccine against SARS-CoV-2 to move into the clinical phase in 2022

A 100% French nasal vaccine against SARS-CoV-2 to move into the clinical phase in 2022

$90 million approved for first-of-its-kind translational research building for mental health

$90 million approved for first-of-its-kind translational research building for mental health

Health Secretary gives blood sample for new genomic sequencing program

Health Secretary gives blood sample for new genomic sequencing program

Scientists identify new approach to overcome resistance to cancer immunotherapy

Scientists identify new approach to overcome resistance to cancer immunotherapy

Owlstone Medical appoints Mark Capone to board of directors

Owlstone Medical appoints Mark Capone to board of directors

GammaDelta Therapeutics initiates first-in-human phase 1 trial of GDX012 for the treatment of acute myeloid leukemia

GammaDelta Therapeutics initiates first-in-human phase 1 trial of GDX012 for the treatment of acute myeloid leukemia

Researchers take major step forward in the development of microbial fuel cells

Researchers take major step forward in the development of microbial fuel cells

OSU-led collaboration proposes broadening of university promotion, tenure criteria and innovation

OSU-led collaboration proposes broadening of university promotion, tenure criteria and innovation

Temple research paves the way for first Phase 1/2 clinical trials of CRISPR-based therapy for HIV

Temple research paves the way for first Phase 1/2 clinical trials of CRISPR-based therapy for HIV

New imaging technique can change the landscape of prostate cancer detection and treatment

New imaging technique can change the landscape of prostate cancer detection and treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.